{"content":"<li class=\"n-box-item date-title\" data-end=\"1510376399\" data-start=\"1510290000\" data-txt=\"Monday, December 23, 2019\">Friday, November 10, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3311265\" data-ts=\"1510353882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311265-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='green'>+21.6%</font>. <a href='https://seekingalpha.com/symbol/TPIC' title='TPI Composites'>TPIC</a> <font color='green'>+4.7%</font>. <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/LUB' title='Luby&#39;s, Inc.'>LUB</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='green'>+2.6%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/HTGC' title='Hercules Capital, Inc.'>HTGC</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='red'>-1.2%</font>. <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='red'>-1.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311265\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MAT $TPIC $HAS - After Hours Gainers / Losers https://seekingalpha.com/news/3311265-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3311265-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311256\" data-ts=\"1510352109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311256-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='green'>+15.9%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='green'>+8.0%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='green'>+6.9%</font>. <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='green'>+5.8%</font>. <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+3.4%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/EPI' title='WisdomTree India Earnings ETF'>EPI</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/IWC' title='iShares Micro-Cap ETF'>IWC</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/EWY' title='iShares MSCI South Korea Capped ETF'>EWY</a> <font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311256\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$URA $UNG $REMX - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3311256-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3311256-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311255\" data-ts=\"1510351625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311255-mattelplus-13_5-on-wsj-report-of-hasbro-takeover-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel +13.5% on WSJ report of Hasbro takeover approach</a></h4><ul>     <li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) has jumped in Friday postmarket trading, <font color='green'>up 13.5%</font>, on a report that Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>) has <a href=\"https://www.wsj.com/articles/hasbro-makes-takeover-approach-to-mattel-1510351281\" target=\"_blank\">made a takeover approach</a>.</li>     <li>Hasbro shares are flat after hours, but <font color='green'>gained 3.1%</font> today.</li>     <li><i>The Wall Street Journal</i> says talks about a HAS/MAT deal are a result of toymakers needing to fight for survival as children start to prefer gadgets.</li>   <li><b>Updated 5:18 p.m.:</b> The approach is a recent one, the <i>WSJ</i> says, but would create a company with a market value of $16B-plus. Hasbro of late has outperformed Mattel, whose shares have <font color='red'>fallen 47%</font> this year and which hired a new chief executive this year after an earlier turnaround effort stalled.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311255\" data-linked=\"Mattel +13.5% on WSJ report of Hasbro takeover approach\" data-tweet=\"$MAT $MAT $HAS - Mattel +13.5% on WSJ report of Hasbro takeover approach https://seekingalpha.com/news/3311255-mattelplus-13_5-on-wsj-report-of-hasbro-takeover-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3311255-mattelplus-13_5-on-wsj-report-of-hasbro-takeover-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>104&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311251\" data-ts=\"1510350967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAND\" target=\"_blank\">BAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311251-bandwidth-closes-first-day-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bandwidth closes first day up 6%</a></h4><ul><li>        Bandwidth (NASDAQ:<a href='https://seekingalpha.com/symbol/BAND' title='Bandwidth, Inc.'>BAND</a>) closes its first day public&nbsp;<font color='green'>up 6%</font>&nbsp;to $21.19.</li><li>               The company had priced its IPO at $20, which was the bottom of its pricing range.&nbsp;</li><li>               Bandwidth <a href=\"https://www.sec.gov/Archives/edgar/data/1514416/000119312517309873/d416018ds1.htm\" target=\"_blank\">brought in</a> $152.1M in revenues in 2016, up from the $137.8M in 2015.&nbsp;</li><li>                  Competitor Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>) closed the day&nbsp;<font color='red'>down 1.47%</font>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3310163-twilio-plus-2_6-percent-mixed-q3-upside-guidance\" target=\"_blank\">Twilio +2.6% after mixed Q3, upside guidance</a> (Nov. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311251\" data-linked=\"Bandwidth closes first day up 6%\" data-tweet=\"$BAND $BAND $TWLO - Bandwidth closes first day up 6% https://seekingalpha.com/news/3311251-bandwidth-closes-first-day-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3311251-bandwidth-closes-first-day-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311235\" data-ts=\"1510348436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311235-vanda-strikes-out-in-appeal-of-thumbs-down-from-european-advisory-group-on-fanaptum-for\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda strikes out in appeal of thumbs down from European advisory group on Fanaptum for schizophrenia</a></h4><ul><li>The European Medicines Agency's Committee for Medicinal Products for Human Use &#40;CHMP&#41; has confirmed its earlier <a href=\"https://seekingalpha.com/pr/16999128-vanda-receives-negative-opinion-marketing-authorization-european-medicines-agency-fanaptum\" target=\"_blank\">refusal </a>of Vanda Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a>) marketing application seeking approval for Fanaptum (oral iloperidone tablets) for the treatment of adults with schizophrenia.</li><li>The company requested a re-examination of the initial negative opinion, issued in July, but to no avail.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280222-european-regulator-rejects-vandas-marketing-application-schizophrenia-med-fanaptum\" target=\"_blank\">European regulator rejects Vanda's marketing application for schizophrenia med Fanaptum</a> (July 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311235\" data-linked=\"Vanda strikes out in appeal of thumbs down from European advisory group on Fanaptum for schizophrenia\" data-tweet=\"$VNDA - Vanda strikes out in appeal of thumbs down from European advisory group on Fanaptum for schizophrenia https://seekingalpha.com/news/3311235-vanda-strikes-out-in-appeal-of-thumbs-down-from-european-advisory-group-on-fanaptum-for?source=tweet\" data-url=\"https://seekingalpha.com/news/3311235-vanda-strikes-out-in-appeal-of-thumbs-down-from-european-advisory-group-on-fanaptum-for\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311231\" data-ts=\"1510347889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAC\" target=\"_blank\">MAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311231-another-nice-session-for-malls-after-dan-loebs-macerich-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another nice session for malls after Dan Loeb&#39;s Macerich stake</a></h4><ul><li>Third Point Thursday disclosed a 1.3% stake in Macerich (NYSE:<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Co.'>MAC</a>) as of September 30. <a href=\"https://www.bloomberg.com/news/articles/2017-11-09/loeb-s-third-point-is-said-to-take-stake-in-mall-owner-macerich-j9ss2lop\" target=\"_blank\">According to Bloomberg</a>, that stake has since been raised to nearly 5% and the hedge fund is expected to push for changes.</li><li>Macerich&nbsp;<font color='green'>skied nearly 10%</font>&nbsp;yesterday and is&nbsp;<font color='green'>higher by 3.15%</font>&nbsp;today.</li><li>This news comes on the heels of Brookfield Asset's <a href=\"https://seekingalpha.com/news/3309253-mall-names-move-higher-ggp-going-private-talks-shopping-centers\" target=\"_blank\">reported interest</a> in purchasing the rest of GGP (GGP <font color='green'>+1%</font>).</li><li>This isn't Macerich's first rodeo. The mall operator was able to fend off activist Land &amp; Buildings in 2015 after it rejected a takeover play by Simon Property Group (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+1.5%</font>).</li><li>Also on the move is Taubman Centers (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color='green'>+5.8%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3311231\" data-linked=\"Another nice session for malls after Dan Loeb&#39;s Macerich stake\" data-tweet=\"$MAC $MAC $BPR - Another nice session for malls after Dan Loeb&#39;s Macerich stake https://seekingalpha.com/news/3311231-another-nice-session-for-malls-after-dan-loebs-macerich-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3311231-another-nice-session-for-malls-after-dan-loebs-macerich-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311225\" data-ts=\"1510346690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311225-stifel-analysts-defend-cruise-liners-following-senate-tax-reform-bill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel analysts defend cruise liners following Senate tax reform bill</a></h4><ul>     <li><a href=\"https://www.streetinsider.com/Analyst+Comments/Buy+Todays+Weakness+in+Cruise+Stock+on+Tax+Worries+-+Stifel+%28CCL%29+%28RCL%29+%28NCLH%29/13492367.html\" target=\"_blank\">Cruise line stocks are finding a defender</a> in the analyst team at Stifel, which thinks today's weakness stems from language in the Senate tax reform bill released yesterday.</li>     <li>Stifel notes that the initial House tax reform bill also included language related to cruise liners which suddenly disappeared, and the firm foresees a similar outcome with the Senate bill given the cruise industry's strong lobbying power in D.C.</li>     <li>The firm suggests using today's weakness in Carnival (<a href='https://seekingalpha.com/symbol/CCL' title='Carnival Corporation'>CCL</a> <font color='red'>-2.3%</font>), Royal Caribbean (<a href='https://seekingalpha.com/symbol/RCL' title='Royal Caribbean Cruises Ltd.'>RCL</a> <font color='red'>-1.9%</font>) and Norwegian Cruise Line (<a href='https://seekingalpha.com/symbol/NCLH' title='Norwegian Cruise Line Holdings Ltd.'>NCLH</a> <font color='red'>-2.5%</font>) as a buying opportunity.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311225\" data-linked=\"Stifel analysts defend cruise liners following Senate tax reform bill\" data-tweet=\"$CCL $CCL $RCL - Stifel analysts defend cruise liners following Senate tax reform bill https://seekingalpha.com/news/3311225-stifel-analysts-defend-cruise-liners-following-senate-tax-reform-bill?source=tweet\" data-url=\"https://seekingalpha.com/news/3311225-stifel-analysts-defend-cruise-liners-following-senate-tax-reform-bill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311223\" data-ts=\"1510345396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XON\" target=\"_blank\">XON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311223-intrexons-q3-miss-pressures-shares-down-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intrexon&#39;s Q3 miss pressures shares, down 23%</a></h4><ul><li>Intrexon (<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='red'>-23.4%</font>) is approaching the end of an ugly day on an 8x surge in volume. Shares have been in the red since the open after the company released Q3 numbers after the close yesterday.</li><li>Revenue was down 6% from a year ago and missed consensus by almost 17%. The company says collaboration and licensing revenues decreased $2.4M due to a decrease in R&amp;D services from some of its partners. Product revenues slipped $1.6M (17%) due to lower demand for cows and live calves.</li><li>Q4 consensus is a loss/share of ($0.21) on revenues of $57M (+16%).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310748-intrexon-misses-0_10-misses-revenue\" target=\"_blank\">Intrexon misses by $0.10, misses on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311223\" data-linked=\"Intrexon&#39;s Q3 miss pressures shares, down 23%\" data-tweet=\"$XON - Intrexon&#39;s Q3 miss pressures shares, down 23% https://seekingalpha.com/news/3311223-intrexons-q3-miss-pressures-shares-down-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3311223-intrexons-q3-miss-pressures-shares-down-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311222\" data-ts=\"1510345373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLDX\" target=\"_blank\">KLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311222-klondex-minesminus-14-after-sharp-q3-miss-reiterates-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Klondex Mines -14% after sharp Q3 miss; reiterates production guidance</a></h4><ul>     <li>Klondex Mines (<a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='red'>-14.1%</font>) plunges to a 52-week low after posting an unexpected <a href=\"https://seekingalpha.com/news/3310847-klondex-mines-misses-0_09-misses-revenue\" target=\"_blank\">Q3 loss</a> and a 12% Y/Y revenue decline due to fewer ounces sold and a lower realized gold price.</li>     <li>KLDX says it mined ~54K gold equiv. oz., produced 41K and sold 38K during Q3, but did not process all mined ore and built stockpiles, both in Nevada and Canada, during the quarter; the company says it is now working through the stockpiles and expects most of the ounces will be processed in Q4.</li>     <li>KLDX reiterates FY 2017 guidance for total consolidated production of 213K-230K gold equiv. oz. at cash cost of $675-$700/oz. sold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311222\" data-linked=\"Klondex Mines -14% after sharp Q3 miss; reiterates production guidance\" data-tweet=\"$KLDX - Klondex Mines -14% after sharp Q3 miss; reiterates production guidance https://seekingalpha.com/news/3311222-klondex-minesminus-14-after-sharp-q3-miss-reiterates-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3311222-klondex-minesminus-14-after-sharp-q3-miss-reiterates-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311221\" data-ts=\"1510345108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311221-reuters-murdoch-called-and-ts-stephenson-to-talk-cnn\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Murdoch called AT&amp;T&#39;s Stephenson to talk about CNN</a></h4><ul>   <li>Fox's Rupert Murdoch called AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+0.5%</font>) chief Randall Stephenson twice in the past six months to <a href=\"https://www.reuters.com/article/us-cnn-murdoch-exclusive/exclusive-rupert-murdoch-twice-discussed-cnn-with-att-ceo-sources-idUSKBN1DA2PY?il=0\" target=\"_blank\">talk about news network CNN</a>, Reuters reports, saying one source says Murdoch offered to buy the network in both conversations.</li>    <li>Another source tells Reuters that Murdoch and Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-0.3%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.4%</font>) have \"zero interest\" in CNN.</li>    <li>The news follows on a heavy week where claims and counterclaims are flying around whether selling CNN came up in AT&amp;T's discussions with the Justice Dept. around its $85B bid for Time Warner (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='green'>+4.3%</font>).</li><li>With all the talk about divesting CNN, it's worth noting the network as an asset is likely worth about $9B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310691-t-chief-stephenson-cnn-sale-factor-doj-time-warner-talks\" target=\"_blank\">AT&amp;T chief Stephenson: CNN sale not a factor in DOJ/Time Warner talks</a> (Nov. 09 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3309918-ft-doj-demanding-cnn-sale-approve-and-t-time-warner-updated\" target=\"_blank\">FT: DOJ demanding CNN sale to approve AT&amp;T/Time Warner (updated)</a> (Nov. 08 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3309875-reuters-doj-pushing-structural-change-asset-sales-t-twx-deal\" target=\"_blank\">Reuters: DOJ pushing 'structural' change (asset sales) in T/TWX deal</a> (Nov. 08 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311221\" data-linked=\"Reuters: Murdoch called AT&amp;T&#39;s Stephenson to talk about CNN\" data-tweet=\"$FOX $FOX $FOXA - Reuters: Murdoch called AT&amp;T&#39;s Stephenson to talk about CNN https://seekingalpha.com/news/3311221-reuters-murdoch-called-and-ts-stephenson-to-talk-cnn?source=tweet\" data-url=\"https://seekingalpha.com/news/3311221-reuters-murdoch-called-and-ts-stephenson-to-talk-cnn\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>125&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311219\" data-ts=\"1510344388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311219-alibabas-singles-day-breaks-5b-in-first-15-minutes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba&#39;s Singles&#39; Day breaks $5B in first 15 minutes</a></h4><ul><li>        Alibaba&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) Singles&rsquo; Day event brought in $5B in the first 15 minutes of sales, according to <a href=\"https://www.cnbc.com/2017/11/10/alibaba-sales-surge-to-5-billion-in-15-minutes-on-singles-day.html\" target=\"_blank\">CNBC</a>.</li><li>                  Last year, the day-long sale brought in $17.8B.    </li><li>               Alibaba shares are&nbsp;<font color='green'>up 0.77%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310588-alibabas-singles-day-sales-event-coming-saturday-top-24b-sales\" target=\"_blank\">Alibaba's Singles' Day sales event coming Saturday, could top $24B in sales</a> (Nov. 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311048-reuters-alibaba-will-announce-us-dollar-bond-sale-next-week\" target=\"_blank\">Reuters: Alibaba will announce US dollar bond sale next week</a> (Nov. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311219\" data-linked=\"Alibaba&#39;s Singles&#39; Day breaks $5B in first 15 minutes\" data-tweet=\"$BABA - Alibaba&#39;s Singles&#39; Day breaks $5B in first 15 minutes https://seekingalpha.com/news/3311219-alibabas-singles-day-breaks-5b-in-first-15-minutes?source=tweet\" data-url=\"https://seekingalpha.com/news/3311219-alibabas-singles-day-breaks-5b-in-first-15-minutes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>178&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311215\" data-ts=\"1510343785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311215-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/RDFN' title='Redfin'>RDFN</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311215\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$XNET $AVID $MTBC - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3311215-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3311215-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311214\" data-ts=\"1510343051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311214-needham-upgrades-viasat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham upgrades ViaSat</a></h4><ul><li>Needham <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171110074627VSAT\" target=\"_blank\">upgrades</a> ViaSat (NASDAQ:<a href='https://seekingalpha.com/symbol/VSAT' title='Viasat, Inc.'>VSAT</a>) from Hold to Buy with a $78 price target.</li><li>Firm cites the upcoming February launch of the ViaSat-2 satellite, accelerating in-flight installs, and potential government wins as tailwinds.</li><li>ViaSat shares are&nbsp;<font color='green'>up 5.27%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310233-viasat-minus-2_4-percent-q2-revenues-decline-miss-expectations\" target=\"_blank\">ViaSat -2.4% as Q2 revenues decline, miss expectations</a> (Nov. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311214\" data-linked=\"Needham upgrades ViaSat\" data-tweet=\"$VSAT - Needham upgrades ViaSat https://seekingalpha.com/news/3311214-needham-upgrades-viasat?source=tweet\" data-url=\"https://seekingalpha.com/news/3311214-needham-upgrades-viasat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311212\" data-ts=\"1510342185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYT\" target=\"_blank\">NYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311212-new-york-times-launching-monthly-section-focused-on-children\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New York Times launching monthly section focused on children</a></h4><ul>   <li><i>The New York Times</i> (<a href=\"http://seekingalpha.com/symbol/NYT\" target=\"_blank\">NYT</a> <font color='green'>+2.2%</font>) is launching a <a href=\"https://seekingalpha.com/pr/16998845-new-york-times-launch-monthly-kids-section\" target=\"_blank\">regular section dedicated to children</a> after seeing the success of a May run at such a section.</li>    <li>It will run a second Kids section Nov. 19, and take the feature monthly starting January 28.</li>    <li>That section will mimic the paper's regular sections, including sports, national news, food, opinion and arts, the company says.</li>    <li>It's also launching a second run at its Puzzle Spectacular, a print-only broadsheet devoted entirely to puzzles, along with the Dec. 17 edition of the paper.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311212\" data-linked=\"New York Times launching monthly section focused on children\" data-tweet=\"$NYT - New York Times launching monthly section focused on children https://seekingalpha.com/news/3311212-new-york-times-launching-monthly-section-focused-on-children?source=tweet\" data-url=\"https://seekingalpha.com/news/3311212-new-york-times-launching-monthly-section-focused-on-children\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311210\" data-ts=\"1510341910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYG\" target=\"_blank\">PCYG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311210-park-city-group-board-recommends-strategic-alternative-search\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Park City Group board recommends strategic alternative search</a></h4><ul><li>        Park City Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a>) shares are&nbsp;<font color='red'>down 3.95%</font>&nbsp;after the Board of Directors <a href=\"https://seekingalpha.com/filing/3760429\" target=\"_blank\">advises</a> hiring a financial advisory firm to explore strategic options.</li><li>                  The news comes after the Q1 report missed EPS and revenue estimates. &nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3310738-park-city-group-misses-0_02-misses-revenue\" target=\"_blank\">Park City Group misses by $0.02, misses on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311210\" data-linked=\"Park City Group board recommends strategic alternative search\" data-tweet=\"$PCYG - Park City Group board recommends strategic alternative search https://seekingalpha.com/news/3311210-park-city-group-board-recommends-strategic-alternative-search?source=tweet\" data-url=\"https://seekingalpha.com/news/3311210-park-city-group-board-recommends-strategic-alternative-search\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311209\" data-ts=\"1510341748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311209-sangamo-therapeutics-up-8-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo Therapeutics up 8% after earnings beat</a></h4><ul><li>Q3 revenue of $11.8M vs. $2.8M a year earlier.</li><li>R&amp;D expenses of $18.4M vs. $17M.</li><li>Full-ear revenue guidance is reiterated at $30M-$40M, with operating expenses of $90M-$100M (includes non-cash stock-based comp). Cash and equivalents are seen at $220M at year-end.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310737-sangamo-therapeutics-beats-0_04-beats-revenue\" target=\"_blank\">Sangamo Therapeutics beats by $0.04, beats on revenue</a> (Nov. 9)</li><li><a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>&nbsp;<font color='green'>+8.3%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3311209\" data-linked=\"Sangamo Therapeutics up 8% after earnings beat\" data-tweet=\"$SGMO - Sangamo Therapeutics up 8% after earnings beat https://seekingalpha.com/news/3311209-sangamo-therapeutics-up-8-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3311209-sangamo-therapeutics-up-8-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311208\" data-ts=\"1510341700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311208-hertzminus-2-following-earlier-gains-analysts-remain-skeptical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz -2% following earlier gains; analysts remain skeptical</a></h4><ul>     <li>Hertz (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-1.9%</font>) shares have turned red in today's trade following a big initial increase after reporting better than expected <a href=\"https://seekingalpha.com/news/3310821-hertz-plus-11-percent-q3-earnings-beat-estimates-better-u-s-pricing\" target=\"_blank\">Q3 earnings</a>, as <a href=\"http://www.barrons.com/articles/hertz-is-in-the-fast-lets-hope-it-doesnt-hit-a-speed-bump-1510337006\" target=\"_blank\">many analysts question</a> whether the strong result can be enduring.</li>     <li>Credit Suisse, which rates HTZ at Underperform with a $10 price target, notes a 3.7% decline in U.S. volumes that the firm says would have missed estimates even after adjusting for hurricanes; it remains skeptical on whether Q3's improvements can be enduring or is more a function of recent high fleet costs.</li>     <li>Morgan Stanley maintains its Underweight rating, believing the fundamentals of the car rental business are not improving and that HTZ eventually will see further and potentially steeper declines.</li>     <li>However, MKM&nbsp;Partners, which rates HTZ as a Buy with a $36 price target, sees Q3 results as \"confirmation that negative pricing and fleet cost trends bottomed and that earnings momentum is turning.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3311208\" data-linked=\"Hertz -2% following earlier gains; analysts remain skeptical\" data-tweet=\"$HTZ - Hertz -2% following earlier gains; analysts remain skeptical https://seekingalpha.com/news/3311208-hertzminus-2-following-earlier-gains-analysts-remain-skeptical?source=tweet\" data-url=\"https://seekingalpha.com/news/3311208-hertzminus-2-following-earlier-gains-analysts-remain-skeptical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311205\" data-ts=\"1510340655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311205-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CGA' title='China Green Agriculture, Inc.'>CGA</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='red'>-13%</font>. PGH <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311205\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$UEC $CDXC $TANH - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3311205-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3311205-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311270\" data-ts=\"1510338007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCI\" target=\"_blank\">JCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311270-johnson-controlsminus-4-analysts-turn-thumbs-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Johnson Controls -4% as analysts turn thumbs down</a></h4><ul>     <li>Johnson Controls (<a href='https://seekingalpha.com/symbol/JCI' title='Johnson Controls International plc'>JCI</a> <font color='red'>-4.1%</font>) falls sharply amid a flurry of negative analyst commentary following yesterday's <a href=\"https://seekingalpha.com/news/3310393-johnson-controls-international-eps-line-beats-revenue\" target=\"_blank\">FQ4 earnings</a> report.</li>     <li>Vertical Research <a href=\"https://thefly.com/thestreet/realmoney/index.php/JCIid2640225/JCI-Johnson-Controls-downgraded-to-Hold-from-Buy-at-Vertical-Research\" target=\"_blank\">downgrades</a> JCI to Hold from Buy with a $40 price target, telling investors the stock is \"stuck in Purgatory.\"</li><li>Wells Fargo <a href=\"https://www.streetinsider.com/Analyst+Comments/Johnson+Controls+%28JCI%29+PT+Lowered+to+%2441+at+Wells+Fargo+on+4Q+Report%3B+North+American+Margin+Headwinds+in+F18/13491836.html\" target=\"_blank\">cuts</a> its stock price target to $41, citing \"North American margin headwinds\" in FY 2018, while Cowen, Citi and Baird trim their respective price targets to $44, $47 and $48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311270\" data-linked=\"Johnson Controls -4% as analysts turn thumbs down\" data-tweet=\"$JCI - Johnson Controls -4% as analysts turn thumbs down https://seekingalpha.com/news/3311270-johnson-controlsminus-4-analysts-turn-thumbs-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3311270-johnson-controlsminus-4-analysts-turn-thumbs-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311198\" data-ts=\"1510337824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREG\" target=\"_blank\">CREG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311198-china-recycling-energy-up-80-after-volatile-morning-no-catalyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Recycling Energy up 80% after volatile morning, no catalyst</a></h4><ul><li>        China Recycling Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a>) shares are&nbsp;<font color='green'>up 80%</font>&nbsp;after a trading halt this morning for volatility.</li><li>               The company has no catalysts driving the boost except for internet speculation that China Recycling could in some way benefit from President Trump&rsquo;s talks with China.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3311198\" data-linked=\"China Recycling Energy up 80% after volatile morning, no catalyst\" data-tweet=\"$CREG - China Recycling Energy up 80% after volatile morning, no catalyst https://seekingalpha.com/news/3311198-china-recycling-energy-up-80-after-volatile-morning-no-catalyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3311198-china-recycling-energy-up-80-after-volatile-morning-no-catalyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311195\" data-ts=\"1510337020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311195-kura-moves-up-ahead-of-investor-day-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura moves up ahead of Investor Day; shares up 9%</a></h4><ul><li>Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+9.3%</font>) has perked up over&nbsp;<font color='green'>18%&nbsp;</font>since Wednesday, albeit on lackluster volume. Next Thursday, November 16, the company will host an <a href=\"https://seekingalpha.com/pr/16998112-kura-oncology-host-investor-day-november-16-2017\" target=\"_blank\">Investor Day</a> during which management will provide a comprehensive overview of lead candidate tipifarnib in head and neck squamous cell carcinoma.</li><li>Yesterday, Citigroup raised its price target to $19 from $15 &#40;BUY&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311195\" data-linked=\"Kura moves up ahead of Investor Day; shares up 9%\" data-tweet=\"$KURA - Kura moves up ahead of Investor Day; shares up 9% https://seekingalpha.com/news/3311195-kura-moves-up-ahead-of-investor-day-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3311195-kura-moves-up-ahead-of-investor-day-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311194\" data-ts=\"1510336980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311194-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/KINS' title='Kingstone Companies Inc'>KINS</a> <font color='green'>+11%</font>.<a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SCM' title='Stellus Capital Investment Corporation'>SCM</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311194\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$HGSH $KINS $QD - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3311194-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3311194-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311193\" data-ts=\"1510336848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311193-reuters-ahead-of-big-overhaul-ge-laying-off-software-sales-staff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Ahead of big overhaul, GE laying off software/sales staff</a></h4><ul>   <li>General Electric (<a href=\"http://seekingalpha.com/symbol/GE\" target=\"_blank\">GE</a> <font color='green'>+1.7%</font>) is <a href=\"https://www.reuters.com/article/us-ge-review-jobs/ge-cutting-staff-ahead-of-new-ceos-monday-overhaul-sources-idUSKBN1DA2HY\" target=\"_blank\">cutting sales staff and other software employees</a> ahead of an expected Monday overhaul announcement from new CEO John Flannery, Reuters reports.</li>    <li>About 100 salespeople in the Americas are affected by layoffs at GE Digital, including those selling the company's Predix software, according to the report.</li>    <li>Flannery has been expected to cut corporate staff at Boston headquarters, and Reuters says those reductions have begun as well.</li>    <li>Cuts at the digital business (which employs about 13,000) aren't just touching sales staff but also software developers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311185-ges-sum-parts-valuation-solution-woes-analyst-says\" target=\"_blank\">GE's sum-of-the-parts valuation not the solution to woes, analyst says</a> (Nov. 10 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311193\" data-linked=\"Reuters: Ahead of big overhaul, GE laying off software/sales staff\" data-tweet=\"$GE - Reuters: Ahead of big overhaul, GE laying off software/sales staff https://seekingalpha.com/news/3311193-reuters-ahead-of-big-overhaul-ge-laying-off-software-sales-staff?source=tweet\" data-url=\"https://seekingalpha.com/news/3311193-reuters-ahead-of-big-overhaul-ge-laying-off-software-sales-staff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311191\" data-ts=\"1510336752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YPF\" target=\"_blank\">YPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311191-ypf-to-hike-crude-investment-argentina-cuts-natural-gas-subsidies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YPF to hike crude investment as Argentina cuts natural gas subsidies</a></h4><ul>     <li>YPF (<a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a> <font color='red'>-4.5%</font>) officials say they are <a href=\"https://www.epmag.com/argentinas-ypf-boost-crude-investment-amid-natural-gas-subsidy-cuts-1668451\" target=\"_blank\">disappointed by cuts in natural gas production subsidies</a> from Argentina's government and plan to re-allocate investment toward crude oil production.</li>     <li>The Argentine state-run company may reduce investment in unconventional gas production in areas where it cannot obtain the full subsidy price of $7.50/MMBtu, CFO Daniel Gonzalez told investors during its earnings conference call.</li>     <li>The government's incentive program providing a minimum price to nat gas production above a pre-determined decline rate expires at the end of this year, and the subsidies then will be available only for  unconventional gas production in the Neuquen Basin, home of the Vaca Muerta shale play.</li>     <li>Gonzalez says the change will benefit YPF&rsquo;s pilot projects in Vaca Muerta but hurt in areas already in production.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311191\" data-linked=\"YPF to hike crude investment as Argentina cuts natural gas subsidies\" data-tweet=\"$YPF - YPF to hike crude investment as Argentina cuts natural gas subsidies https://seekingalpha.com/news/3311191-ypf-to-hike-crude-investment-argentina-cuts-natural-gas-subsidies?source=tweet\" data-url=\"https://seekingalpha.com/news/3311191-ypf-to-hike-crude-investment-argentina-cuts-natural-gas-subsidies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311190\" data-ts=\"1510336638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZOES\" target=\"_blank\">ZOES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311190-zoes-kitchenplus-11_8-after-mixed-q3-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoe&#39;s Kitchen +11.8% after mixed Q3, in-line guidance</a></h4><ul><li>        Zoe&rsquo;s Kitchen (NYSE:<a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a>) shares are&nbsp;<font color='green'>up 11.8%</font>&nbsp;after the Q3 results beat EPS estimates but missed on revenue. FY17 guidance has revenue from $314M to $316M compared to the $316.28M consensus.</li><li>               Key metrics: comp restaurant sales, -0.5% (due to Hurricanes Harvey and Irma) ; new company-owned stores, 11; restaurant contribution margin, 18.8%.&nbsp;</li><li>                  Financials: Adjusted EBITDA, $6.9M (+4.7% Y/Y); operating expenses, $76.6M; cash and equivalents, $4.6M; total debt, $42.1M.    </li><li>                  More FY17 guidance: comp restaurant sales, -2% to -2.5%; new company-owned stores, 38 to 40; restaurant contribution margin, 18.3% to 18.5%. &nbsp;   </li><li>               <a href=\"https://seekingalpha.com/pr/16998104-zoes-kitchen-announces-third-quarter-2017-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310752-zoes-beats-0_01-misses-revenue\" target=\"_blank\">Zoe's beats by $0.01, misses on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311190\" data-linked=\"Zoe&#39;s Kitchen +11.8% after mixed Q3, in-line guidance\" data-tweet=\"$ZOES - Zoe&#39;s Kitchen +11.8% after mixed Q3, in-line guidance https://seekingalpha.com/news/3311190-zoes-kitchenplus-11_8-after-mixed-q3-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3311190-zoes-kitchenplus-11_8-after-mixed-q3-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311189\" data-ts=\"1510336595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311189-big-block-of-trades-sends-gold-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big block of trades sends gold down 1%</a></h4><ul><li>Just after 11:10 AM ET, <a href=\"https://www.bloomberg.com/news/articles/2017-11-10/gold-futures-4-million-ounce-trade-triggers-sell-off-chart?cmpid=socialflow-twitter-business&amp;utm_content=business&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social\" target=\"_blank\">nearly 40K gold futures</a> contracts traded in just a few minutes, <a href=\"https://finviz.com/futures_charts.ashx?t=GC&amp;p=m5\" target=\"_blank\">knocking the price</a> down almost 1%.</li><li>The metal's remained there since,&nbsp;<font color='red'>down 0.9%</font>&nbsp;on the session at $1,276 per ounce. <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>&nbsp;<font color='red'>-0.8%</font></li><li>The move has spread to the miners, with the <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>&nbsp;<font color='red'>off 1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='ETFS Physical Swiss Gold Trust ETF'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3311189\" data-linked=\"Big block of trades sends gold down 1%\" data-tweet=\"$GLD $GDX $NUGT - Big block of trades sends gold down 1% https://seekingalpha.com/news/3311189-big-block-of-trades-sends-gold-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3311189-big-block-of-trades-sends-gold-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311186\" data-ts=\"1510335634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311186-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+65%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RELY' title='Real Industry, Inc.'>RELY</a> <font color='red'>-63%</font>. <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/KONA' title='Kona Grill, Inc.'>KONA</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/LPTH' title='LightPath Technologies, Inc.'>LPTH</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/ESL' title='Esterline Technologies Corporation'>ESL</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CVO' title='Cenveo, Inc.'>CVO</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/GRAM-OLD' title='Graña y Montero'>GRAM-OLD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311186\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CREG $OMER $OHGI - Midday Gainers / Losers https://seekingalpha.com/news/3311186-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3311186-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311182\" data-ts=\"1510335527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311182-anthera-continues-up-move-after-completing-enrollment-in-late-stage-sollpura-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera continues up move after completing enrollment in late-stage Sollpura study; shares ahead 9%</a></h4><ul><li>Nano cap Anthera Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='green'>+8.6%</font>) adds to yesterday's breakout on triple normal volume. Shares have jumped ~<font color='green'>30%</font>&nbsp;since then after the company <a href=\"https://seekingalpha.com/pr/16997161-anthera-pharmaceuticals-announces-completion-recruitment-phase-3-result-clinical-study\" target=\"_blank\">announced </a>the completion of enrollment in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03051490?term=anthera+pharmaceuticals&amp;phase=2&amp;draw=1&amp;rank=1\" target=\"_blank\">RESULT</a>, assessing Sollpura for the treatment of exocrine pancreatic insufficiency &#40;EPI&#41; caused by cystic fibrosis.</li><li>The primary endpoint is non-inferiority to porcine pancreatic enzyme replacement therapy &#40;PERT&#41; [J&amp;J's <a href=\"https://www.pancreaze.net/\" target=\"_blank\">PANCREAZE&nbsp;</a>(pancrelipase)] at week 8 as measured by coefficient of fat absorption &#40;CFA&#41;. Topline results should be available in Q1 2018.</li><li>An earlier Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02279498?term=anthera+pharmaceuticals&amp;phase=2&amp;draw=1&amp;rank=4\" target=\"_blank\">SOLUTION</a>, failed to achieve the same endpoint.</li><li><a href=\"https://www.anthera.com/product-pipeline/sollpura/\" target=\"_blank\">Sollpura&nbsp;</a>is a non-porcine PERT containing a proprietary engineered cross-linked formulation of crystalline lipase, crystalline protease and amorphous amylase. The company says its solubility and stability offers a more patient-friendly alternative for those who cannot swallow multiple pills or require gastric tubes in order to maintain their nutritional health.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3232594-anthera-drops-66-percent-sollpura-misses-study-target\" target=\"_blank\">Anthera drops 66% as Sollpura misses study target</a> (Dec. 27, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311182\" data-linked=\"Anthera continues up move after completing enrollment in late-stage Sollpura study; shares ahead 9%\" data-tweet=\"$ANTH - Anthera continues up move after completing enrollment in late-stage Sollpura study; shares ahead 9% https://seekingalpha.com/news/3311182-anthera-continues-up-move-after-completing-enrollment-in-late-stage-sollpura-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3311182-anthera-continues-up-move-after-completing-enrollment-in-late-stage-sollpura-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311185\" data-ts=\"1510335313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311185-ges-sum-of-parts-valuation-not-solution-to-woes-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE&#39;s sum-of-the-parts valuation not the solution to woes, analyst says</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+1.8%</font>) pushes back above $20 in today's trade but Cowen analyst Gautam Khanna thinks shares <a href=\"http://www.barrons.com/articles/why-ge-could-be-worth-even-less-than-you-think-1510325302\" target=\"_blank\">may have more downside ahead</a>, as the firm reiterates its Market Perform rating on the stock.</li>     <li>Khanna says his sum-of-the-parts analysis puts GE's breakup value at $11-$15, meaning such a move would be a \"value destructive proposition.\"</li>     <li>\"We see no economic argument for a full-scale break-up of the company, and thus no quick fix for the stock,\" Khanna writes. \"The turnaround will take time, and... the eventual FCF/share recovery will be to a lower level than commonly perceived.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3311185\" data-linked=\"GE&#39;s sum-of-the-parts valuation not the solution to woes, analyst says\" data-tweet=\"$GE - GE&#39;s sum-of-the-parts valuation not the solution to woes, analyst says https://seekingalpha.com/news/3311185-ges-sum-of-parts-valuation-not-solution-to-woes-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3311185-ges-sum-of-parts-valuation-not-solution-to-woes-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311184\" data-ts=\"1510335211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HA\" target=\"_blank\">HA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311184-hawaiian-holdings-up-after-competitor-ends-flights-ahead-of-chapter-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hawaiian Holdings up after competitor ends flights ahead of Chapter 7</a></h4><ul><li>        Hawaiian Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a>) parent company is trading&nbsp;<font color='green'>up 8.14%</font>&nbsp;after competitor Island Air <a href=\"http://www.mauinews.com/news/local-news/2017/11/island-air-ends-37-years-of-flying-today/\" target=\"_blank\">abruptly closes down</a> as it prepares to file for Chapter 7 on Monday.</li><li>               Island Air&rsquo;s final flight, after 37 years in operation, will happen tonight. The company stopped taking reservations yesterday but then decided to end flights.&nbsp;</li><li>               Hawaiian Air has stepped up to try and accommodate passengers holding tickets for later flights that now won&rsquo;t happen.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294440-load-factor-tops-86-percent-hawaiian-airlines\" target=\"_blank\">Load factor tops 86% at Hawaiian Airlines</a> (Sept. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311184\" data-linked=\"Hawaiian Holdings up after competitor ends flights ahead of Chapter 7\" data-tweet=\"$HA - Hawaiian Holdings up after competitor ends flights ahead of Chapter 7 https://seekingalpha.com/news/3311184-hawaiian-holdings-up-after-competitor-ends-flights-ahead-of-chapter-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3311184-hawaiian-holdings-up-after-competitor-ends-flights-ahead-of-chapter-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311179\" data-ts=\"1510334176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311179-arena-completes-enrollment-in-mid-stage-etrasimod-study-in-uc-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena completes enrollment in mid-stage etrasimod study in UC; shares up 1%</a></h4><ul><li>Arena Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color='green'>+1.4%</font>) hits the <a href=\"https://seekingalpha.com/pr/16998967-arena-pharmaceuticals-completes-full-enrollment-etrasimod-phase-2-clinical-study-ulcerative\" target=\"_blank\">enrollment target</a> of 157 subjects in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02447302?term=etrasimod&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating etrasimod in patients with ulcerative colitis &#40;UC&#41;.</li><li>The primary endpoint is the improvement in UC symptoms as measured by Mayo Clinic Score at week 12 compared to placebo. Topline results should be available in Q1 2018.</li><li>Etrasimod (APD334) is an orally available next-generation sphingosine 1-phosphate (S1P) receptor modulator. Selected binding to subtype S1PR1 leads to anti-inflammatory activity by its (theorized) interference with the migration of a specific subset of activated lymphocytes to sites of inflammation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311179\" data-linked=\"Arena completes enrollment in mid-stage etrasimod study in UC; shares up 1%\" data-tweet=\"$ARNA - Arena completes enrollment in mid-stage etrasimod study in UC; shares up 1% https://seekingalpha.com/news/3311179-arena-completes-enrollment-in-mid-stage-etrasimod-study-in-uc-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3311179-arena-completes-enrollment-in-mid-stage-etrasimod-study-in-uc-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311177\" data-ts=\"1510333835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311177-finish-line-off-nearly-12-after-cowen-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finish Line off nearly 12% after Cowen downgrade</a></h4><ul><li>Aggressively undercutting Nike, Adidas, and Under Armour on price isn't a sustainable strategy, says Cowen analyst John Kernan, downgrading Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='red'>-11.6%</font>) to Underperform.</li><li>The \"cash burn will begin soon,\" he says, expecting Q3 to show a fourth straight decline in comparable sales.</li><li>His $7 price target suggests another&nbsp;<font color='red'>20% downside</font>.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3311177\" data-linked=\"Finish Line off nearly 12% after Cowen downgrade\" data-tweet=\"$FINL - Finish Line off nearly 12% after Cowen downgrade https://seekingalpha.com/news/3311177-finish-line-off-nearly-12-after-cowen-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3311177-finish-line-off-nearly-12-after-cowen-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311176\" data-ts=\"1510333548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311176-disney-rebounds-shifts-focus-to-streaming-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney rebounds as it shifts focus to streaming plans</a></h4><ul>   <li>Rebounding from a <a href=\"https://seekingalpha.com/news/3310764-disney-minus-2_9-percent-studio-broadcast-networks-sink-q4-revenues\" target=\"_blank\">disappointing earnings report</a>, Walt Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) is <font color='green'>up 2.6%</font> today as analysts digest <a href=\"https://seekingalpha.com/news/3310877-disney-call-new-streaming-details-still-star-wars\" target=\"_blank\">news from its earnings call</a> on its streaming-video plans as well as yet another trilogy of <i>Star Wars</i> films.</li>    <li>Bob Iger revealed plans to roll out the ESPN Plus streaming service in the spring, and suggested the company might pursue early uptake of 2019's Disney-branded streaming service by pricing it \"substantially\" cheaper than Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color='red'>-1.9%</font>) -- though acknowledging it will have much less content than Netflix at first.</li>    <li>The company's making the right steps with its plans to target evolving media consumers with the two streaming services, JPMorgan's Alexia Quadrani says. The next two fiscal years look good for the film slate as well, she notes, with a pair of <i>Star Wars</i> canon films yet ahead, and another trilogy on the way along with stand-alone films like <i>Solo.</i> She has an Overweight rating and $125 price target, implying 19% upside.</li>    <li>Goldman Sachs kept the company at Conviction Buy and raised its price target to $120 from $115, noting <a href=\"https://www.streetinsider.com/Analyst+Comments/Walt+Disney+%28DIS%29+PT+Raised+to+%24120+at+Goldman+Sachs+Citing+Improving+ESPN+Trends+And+EPS+Growth+Inflection/13491319.html\" target=\"_blank\">trends are improving at ESPN</a>.</li>    <li>Macquarie hoped for more clarity on 2018, and has raised its price target to $100 (current price is $105.38). And Jefferies reiterated its Hold rating.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311176\" data-linked=\"Disney rebounds as it shifts focus to streaming plans\" data-tweet=\"$DIS $DIS $NFLX - Disney rebounds as it shifts focus to streaming plans https://seekingalpha.com/news/3311176-disney-rebounds-shifts-focus-to-streaming-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3311176-disney-rebounds-shifts-focus-to-streaming-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311174\" data-ts=\"1510333332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311174-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> XNY <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311174\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$DXF $FOSL $WATT - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3311174-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3311174-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311171\" data-ts=\"1510333173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETX\" target=\"_blank\">PETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311171-european-advisory-group-backs-aratanas-galliprant-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Aratana&#39;s Galliprant; shares ahead 2%</a></h4><ul><li>The European Medicines Agency's Committee for Medicinal Products for Veterinary Use &#40;CVMP&#41; adopts a <a href=\"https://seekingalpha.com/pr/16998968-elanco-aratana-announce-positive-opinion-galliprant-grapiprant-tablets-europe\" target=\"_blank\">positive opinion</a> recommending approval for Aratana Therapeutics' (<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='green'>+1.7%</font>) GALLIPRANT (grapiprant tablets) for the treatment of pain associated with mild-to-moderate osteoarthritis in dogs.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>Aratana licensed global exclusive rights to GALLIPRANT to Eli Lilly's (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-1.4%</font>) Elanco Animal Health unit. The two companies will co-promote in the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311171\" data-linked=\"European advisory group backs Aratana&#39;s Galliprant; shares ahead 2%\" data-tweet=\"$PETX $PETX $LLY - European advisory group backs Aratana&#39;s Galliprant; shares ahead 2% https://seekingalpha.com/news/3311171-european-advisory-group-backs-aratanas-galliprant-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3311171-european-advisory-group-backs-aratanas-galliprant-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311163\" data-ts=\"1510332347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311163-inovio-cancer-candidates-show-positive-effect-in-early-stage-studies-shares-ahead-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio cancer candidates show positive effect in early-stage studies; shares ahead 4%</a></h4><ul><li>Inovio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+4.1%</font>) perks up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16998920-inovio-pharmaceuticals-presents-immuno-oncology-advancements-society-immunotherapy-cancer\" target=\"_blank\">announcement </a>of positive results for two of its cancer candidates in Phase 1 studies. The data were presented at the SITC Annual Meeting in National Harbor, MD.</li><li>INO-3112 (now MEDI0457 by licensee AstraZeneca), a T-cell activation immunotherapy, showed antigen-specific T-cell stimulation, including a complete response in a patient with head and neck cancer who also received Bristol-Myers Squibb's Opdivo (nivolumab).</li><li>INO-1400, an hTERT-targeting immunotherapy, generated hTERT-specific IFN-&gamma;-secreting T cells which suggests an ability to surmount immune tolerance. High levels of hTERT (human telomerase reverse transcriptase) have been observed in a range of tumor types.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311163\" data-linked=\"Inovio cancer candidates show positive effect in early-stage studies; shares ahead 4%\" data-tweet=\"$INO - Inovio cancer candidates show positive effect in early-stage studies; shares ahead 4% https://seekingalpha.com/news/3311163-inovio-cancer-candidates-show-positive-effect-in-early-stage-studies-shares-ahead-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3311163-inovio-cancer-candidates-show-positive-effect-in-early-stage-studies-shares-ahead-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311165\" data-ts=\"1510331740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGHEF\" target=\"_blank\">PGHEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311165-pengrowth-energyminus-14-production-declines-drag-down-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pengrowth Energy -14% as production declines drag down Q3 results</a></h4><ul>     <li>Pengrowth Energy (PGH <font color='red'>-14.4%</font>) plunges after reporting a <a href=\"https://seekingalpha.com/news/3311057-pengrowth-energy-eps-0_26\" target=\"_blank\">Q3 net loss</a> nearly triple the loss in the year-ago period and a 37% Y/Y revenue reduction.</li>     <li>PGH says Q3 production fell 36% Y/Y to slightly more than 35K boe/day from more than 55K boe/day in the year-ago quarter, citing sold properties, natural declines and lower volumes due to planned maintenance activities on existing properties.</li>     <li>RBC Capital downgrades shares to Underperform from Sector Perform until visibility improves; the firm sees PGH's remaining investment options as attractive following a  prolonged restructuring process but funding Lindbergh Phase 2 is a tall order (source:&nbsp;Briefing.com).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311165\" data-linked=\"Pengrowth Energy -14% as production declines drag down Q3 results\" data-tweet=\"$PGHEF - Pengrowth Energy -14% as production declines drag down Q3 results https://seekingalpha.com/news/3311165-pengrowth-energyminus-14-production-declines-drag-down-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3311165-pengrowth-energyminus-14-production-declines-drag-down-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311153\" data-ts=\"1510330802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WD\" target=\"_blank\">WD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311153-walker-dunlop-down-7-gses-cut-buys-of-multifamily-loans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walker &amp; Dunlop down 7% as GSEs could cut buys of multifamily loans</a></h4><ul><li>via Bloomberg</li><li>The hot-handed commercial lender woke up to some bad news this morning, with <a href=\"https://www.cmalert.com/\" target=\"_blank\">Commercial Mortgage Alert suggesting</a> agency lenders expect Fannie Mae and Freddie Mac to trim purchases of multifamily mortgages next year.</li><li>Not a huge deal, except that Walker &amp; Dunlop (NYSE:<a href='https://seekingalpha.com/symbol/WD' title='Walker & Dunlop, Inc.'>WD</a>) - after an 80% run higher Y/Y - is priced for perfection, says Wedbush's Jason Weaver.</li><li>Shares&nbsp;<font color='red'>down 7%</font>&nbsp;today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311153\" data-linked=\"Walker &amp; Dunlop down 7% as GSEs could cut buys of multifamily loans\" data-tweet=\"$WD - Walker &amp; Dunlop down 7% as GSEs could cut buys of multifamily loans https://seekingalpha.com/news/3311153-walker-dunlop-down-7-gses-cut-buys-of-multifamily-loans?source=tweet\" data-url=\"https://seekingalpha.com/news/3311153-walker-dunlop-down-7-gses-cut-buys-of-multifamily-loans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311151\" data-ts=\"1510330630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311151-wheaton-precious-metalsminus-3-production-declines-dent-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wheaton Precious Metals -3% as production declines dent Q3 results</a></h4><ul>     <li>Wheaton Precious Metals (<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a> <font color='red'>-3.4%</font>) is lower after posting in-line <a href=\"https://seekingalpha.com/news/3310935-wheaton-precious-metals-eps-line-misses-revenue\" target=\"_blank\">Q3 earnings</a> on 13% lower revenues vs. a year ago, as lower attributable production and lower metals prices <a href=\"http://www.miningweekly.com/article/wheaton-precious-metals-posts-20-dip-in-q3-profit-2017-11-10\" target=\"_blank\">weighed  on the bottom line</a>.</li><li>WPM says it sold 5.8M oz. of silver, 6% lower than in the year-ago quarter, and 82.5K oz. of gold, down 3% Y/Y; the average realized silver price fell 14% Y/Y to $16.87/oz. and the average realized gold price slipped 4% to $1,283/oz,</li><li>WPM attributes the reduced silver output to 17% lower silver production from Primero Mining&rsquo;s struggling San Dimas mine in Mexico and an 18% drop in silver output at Hudbay's Constancia mine in Peru.</li><li>For the full year, WPM estimates attributable production of 28M silver oz. and 340K gold oz..</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311151\" data-linked=\"Wheaton Precious Metals -3% as production declines dent Q3 results\" data-tweet=\"$WPM - Wheaton Precious Metals -3% as production declines dent Q3 results https://seekingalpha.com/news/3311151-wheaton-precious-metalsminus-3-production-declines-dent-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3311151-wheaton-precious-metalsminus-3-production-declines-dent-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311148\" data-ts=\"1510330053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDFN\" target=\"_blank\">RDFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311148-redfin-shares-down-8_5-after-q3-misses-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Redfin shares down 8.5% after Q3 misses, in-line guidance</a></h4><ul><li>        Redfin (NASDAQ:<a href='https://seekingalpha.com/symbol/RDFN' title='Redfin'>RDFN</a>) shares are&nbsp;<font color='red'>down 8.5%</font>&nbsp;after a Q3 report that missed EPS and revenue estimates. Q4 guidance has revenue from $89.2M to $93.2M compared to the $90.1M consensus.</li><li>               Key metrics: U.S. existing home sale by value market share, 0.71% (+0.14%); monthly active visitors to website and app, 24M (+38%).&nbsp;</li><li>               Financials: Gross margin, 36% (-2% Y/Y); operating expenses, $29.1M (+15%); &nbsp;cash and equivalents, $64M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16998027-redfin-third-quarter-2017-revenue-35-percent-year-year-109_5-million\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310723-redfin-misses-0_01-misses-revenue\" target=\"_blank\">Redfin misses by $0.01, misses on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311148\" data-linked=\"Redfin shares down 8.5% after Q3 misses, in-line guidance\" data-tweet=\"$RDFN - Redfin shares down 8.5% after Q3 misses, in-line guidance https://seekingalpha.com/news/3311148-redfin-shares-down-8_5-after-q3-misses-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3311148-redfin-shares-down-8_5-after-q3-misses-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311124\" data-ts=\"1510329885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311124-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311124\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$OMER $EKSO $SGMO - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3311124-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3311124-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311141\" data-ts=\"1510329252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MESO\" target=\"_blank\">MESO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311141-mesoblasts-mpc-therapy-shows-durable-effect-in-mid-stage-ra-study-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mesoblast&#39;s MPC therapy shows durable effect in mid-stage RA study; shares ahead 2%</a></h4><ul><li>Thinly traded micro cap Mesoblast Limited (<a href='https://seekingalpha.com/symbol/MESO' title='Mesoblast'>MESO</a> <font color='green'>+2%</font>) was up over&nbsp;<font color='green'>9%</font>&nbsp;early in the session in response to <a href=\"https://seekingalpha.com/pr/16998884-mesoblast-phase-2-trial-results-show-early-durable-effects-single-mesenchymal-precursor-cell\" target=\"_blank\">positive results</a> from a 48-subject Phase 2 clinical trial evaluating its proprietary mesenchymal precursor cells (MPCs) over 52 weeks in patients with refractory rheumatoid arthritis &#40;RA&#41;. The data were presented at the ACR Annual Meeting in San Diego.</li><li>A single intravenous MPC infusion improved clinical symptoms, function, disease activity and patient-reported outcomes. The 2M MPC/kg dose produced the best responses although specific numerical results are not disclosed.</li><li>The most significant benefits over 52 weeks were observed in RA patients who has failed less than three prior lines of biologic treatment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311141\" data-linked=\"Mesoblast&#39;s MPC therapy shows durable effect in mid-stage RA study; shares ahead 2%\" data-tweet=\"$MESO - Mesoblast&#39;s MPC therapy shows durable effect in mid-stage RA study; shares ahead 2% https://seekingalpha.com/news/3311141-mesoblasts-mpc-therapy-shows-durable-effect-in-mid-stage-ra-study-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3311141-mesoblasts-mpc-therapy-shows-durable-effect-in-mid-stage-ra-study-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311142\" data-ts=\"1510329011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSS\" target=\"_blank\">KSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311142-kohls-seen-well-positioned-for-holiday-season-in-baird-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kohl&#39;s seen as well-positioned for holiday season in Baird upgrade</a></h4><ul>     <li>Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='green'>+3%</font>) is <a href=\"https://www.marketwatch.com/story/kohls-upgraded-to-outperform-at-baird-as-company-looks-well-positioned-heading-into-the-holidays-2017-11-10\" target=\"_blank\">upgraded</a>  to Outperform from Neutral with a $47 price target at Baird, which says the company is well positioned for the upcoming holiday season thanks to an improving product portfolio and strong loyalty position</li>     <li>Meanwhile, cost savings and inventory  reduction initiatives provide strong near-term visibility into KSS's free cash flow.</li>     <li>Even if its thesis is wrong, the firm still sees KSS as favorable because of a 5%-plus dividend yield, buybacks and takeout speculation protecting downside.</li>     <li>\"Looking ahead, we believe a more pragmatic growth outlook from management, aggressive actions on the cost front, and momentum with traffic and omni-channel initiatives result in better risk/reward for shares,\" according to Baird.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311142\" data-linked=\"Kohl&#39;s seen as well-positioned for holiday season in Baird upgrade\" data-tweet=\"$KSS - Kohl&#39;s seen as well-positioned for holiday season in Baird upgrade https://seekingalpha.com/news/3311142-kohls-seen-well-positioned-for-holiday-season-in-baird-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3311142-kohls-seen-well-positioned-for-holiday-season-in-baird-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311140\" data-ts=\"1510328374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAN\" target=\"_blank\">AAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311140-raymond-james-buys-dip-in-aarons\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James buys the dip in Aaron&#39;s</a></h4><ul><li>The post-earnings selloff is \"well overdone\" says analyst Budd Bugatch, upgrading Aaron's (<a href='https://seekingalpha.com/symbol/AAN' title='Aaron&#39;s Inc.'>AAN</a> <font color='green'>+2.8%</font>) to Strong Buy from Market Perform.</li><li>A check of the past shows hurricanes actually boost revenues several quarters after they occur.</li><li>In the meantime, the company's balance sheet and financial condition remain strong, and give the management the flexibility to consider strategic alternatives.</li><li>His $42 price target suggests&nbsp;<font color='green'>20% upside</font>.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3311140\" data-linked=\"Raymond James buys the dip in Aaron&#39;s\" data-tweet=\"$AAN - Raymond James buys the dip in Aaron&#39;s https://seekingalpha.com/news/3311140-raymond-james-buys-dip-in-aarons?source=tweet\" data-url=\"https://seekingalpha.com/news/3311140-raymond-james-buys-dip-in-aarons\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311133\" data-ts=\"1510327156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYX\" target=\"_blank\">AYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311133-alteryx-up-15_4-after-q3-beats-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alteryx up 15.4% after Q3 beats, upside guidance</a></h4><ul><li>        Alteryx (NYSE:<a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a>) shares are&nbsp;<font color='green'>up 15.4%</font>&nbsp;after Q3 results beat EPS and revenue estimates. Q4 guidance has revenue from $35.5M to $36M (consensus: $34.67M) and EPS from -$0.02 to -$0.03 (consensus: -$0.08).</li><li>        FY17 guidance: revenue, $128.5M to $129M (consensus: $125.49M); EPS, -$0.15 to -$0.17 (consensus: -$0.33). &nbsp;</li><li>        <a href=\"https://seekingalpha.com/pr/16998239-alteryx-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3310805-alteryx-beats-0_10-beats-revenue\" target=\"_blank\">Alteryx beats by $0.10, beats on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311133\" data-linked=\"Alteryx up 15.4% after Q3 beats, upside guidance\" data-tweet=\"$AYX - Alteryx up 15.4% after Q3 beats, upside guidance https://seekingalpha.com/news/3311133-alteryx-up-15_4-after-q3-beats-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3311133-alteryx-up-15_4-after-q3-beats-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311131\" data-ts=\"1510326583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MET\" target=\"_blank\">MET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311131-sandler-oneill-rings-register-on-metlife\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sandler O&#39;Neill rings the register on MetLife</a></h4><ul><li>The buy thesis has played out, says analyst John Barnidge, noting MetLife's (NYSE:<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a>) significant outperformance since the Brighthouse spinoff.</li><li>The capital return story has been priced in, as have expectations for improved ROE, and regulatory relief. What's the next catalyst to spark shares higher?</li><li>He downgrades to Hold from Buy and cuts his price target to $57 from $60.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='red'>down 1.5%</font>&nbsp;to $52.03.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311131\" data-linked=\"Sandler O&#39;Neill rings the register on MetLife\" data-tweet=\"$MET - Sandler O&#39;Neill rings the register on MetLife https://seekingalpha.com/news/3311131-sandler-oneill-rings-register-on-metlife?source=tweet\" data-url=\"https://seekingalpha.com/news/3311131-sandler-oneill-rings-register-on-metlife\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311130\" data-ts=\"1510326540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVID\" target=\"_blank\">AVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311130-avid-technologyplus-22_5-after-mixed-q3-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Technology +22.5% after mixed Q3, upside guidance</a></h4><ul><li>        Avid Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a>) shares are&nbsp;<font color='green'>up 22.5%</font>&nbsp;after yesterday&rsquo;s Q3 results missed EPS estimates but beat on revenue. Q4 guidance has revenue from $100M to $113M compared to the $106.51M consensus.</li><li>               Key metrics: Bookings, $107.9M; Non-GAAP gross margin, 59.3%; operating expenses $53.9M; adjusted EBITDA, $11.5M; adjusted FCF, $0.5M; cash and equivalents, $44M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16998115-avid-technology-announces-q3-2017-results-issues-q4-2017-guidance\" target=\"_blank\">Press release</a>&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310810-avid-misses-0_06-beats-revenue\" target=\"_blank\">Avid misses by $0.06, beats on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311130\" data-linked=\"Avid Technology +22.5% after mixed Q3, upside guidance\" data-tweet=\"$AVID - Avid Technology +22.5% after mixed Q3, upside guidance https://seekingalpha.com/news/3311130-avid-technologyplus-22_5-after-mixed-q3-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3311130-avid-technologyplus-22_5-after-mixed-q3-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311125\" data-ts=\"1510325889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311125-macys-be-amazons-next-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Could Macy&#39;s be Amazon&#39;s next target?</a></h4><ul><li>The struggling retailer zoomed higher yesterday after earnings weren't as bad as feared, and is&nbsp;<font color='green'>up another 2.4%</font>&nbsp;this morning.</li><li><em>Barron's</em> last week suggested Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) could buy Kohl's if it wants to get into brick and mortar department stores. If that's the case, says Dealreporter, Amazon ought to focus on \"quality over quantity,\" and have a look at Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310489-macys-beats-0_04-misses-revenue\" target=\"_blank\">Macy's beats by $0.04, misses on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311125\" data-linked=\"Could Macy&#39;s be Amazon&#39;s next target?\" data-tweet=\"$AMZN $AMZN $M - Could Macy&#39;s be Amazon&#39;s next target? https://seekingalpha.com/news/3311125-macys-be-amazons-next-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3311125-macys-be-amazons-next-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311120\" data-ts=\"1510325259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311120-canadian-solar-upped-to-buy-roth-amid-overwhelming-sense-of-cynicism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar upped to Buy at Roth amid &#39;overwhelming sense of cynicism&#39;</a></h4><ul>     <li>Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+7.2%</font>) opens higher after Roth Capital <a href=\"https://thefly.com/thestreet/realmoney/index.php/CSIQid2640132/CSIQ-Roth-Capital-upgrades-Canadian-Solar-amid-overwhelming-sense-of-cynicism\" target=\"_blank\">upgrades shares to Buy</a> from Neutral and raises its price target to $24 from $15, seeing an attractive entry point for investors after CSIQ sank 11% yesterday following disappointing <a href=\"https://seekingalpha.com/news/3310337-canadian-solar-misses-0_04-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Roth believes an \"overwhelming sense of cynicism\" is now priced in and sees \"real asset value\" at CSIQ, as the firm's sum-of-the-parts analysis suggests the stock should be worth $24; the company's Japanese portfolio alone is worth $9/share, the firm says.</li><li>Roth also expects a balance sheet transformation at CSIQ over the next six months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311120\" data-linked=\"Canadian Solar upped to Buy at Roth amid &#39;overwhelming sense of cynicism&#39;\" data-tweet=\"$CSIQ - Canadian Solar upped to Buy at Roth amid &#39;overwhelming sense of cynicism&#39; https://seekingalpha.com/news/3311120-canadian-solar-upped-to-buy-roth-amid-overwhelming-sense-of-cynicism?source=tweet\" data-url=\"https://seekingalpha.com/news/3311120-canadian-solar-upped-to-buy-roth-amid-overwhelming-sense-of-cynicism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311117\" data-ts=\"1510324515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311117-analysts-raise-nvidia-price-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Nvidia price targets after earnings</a></h4><ul><li>        Stifel <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171110090215NVDA\" target=\"_blank\">raises</a> its Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) price target from $110 to $184 after yesterday&rsquo;s earnings report.</li><li>               The firm cites outperformance in the datacenter and PC gaming sectors and says the company withstood competition from AMD.&nbsp;</li><li>               Other actions: B. Riley <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171110085714NVDA\" target=\"_blank\">raises</a> its price target from $250 to $270, and Mizuho raises Nvidia from $220 to $225. &nbsp;&nbsp;</li><li>Nvidia shares are&nbsp;<font color='green'>up 4.26%</font>.&nbsp; &nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310871-nvidia-reports-q3-beats-upside-guidance-strength-datacenter\" target=\"_blank\">Nvidia reports Q3 beats, upside guidance, and strength in Datacenter</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311117\" data-linked=\"Analysts raise Nvidia price targets after earnings\" data-tweet=\"$NVDA - Analysts raise Nvidia price targets after earnings https://seekingalpha.com/news/3311117-analysts-raise-nvidia-price-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3311117-analysts-raise-nvidia-price-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311115\" data-ts=\"1510324110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311115-rokuplus-5_7-after-disclosing-danish-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +5.7% after disclosing Danish acquisition</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) is <font color='green'>up 5.7%</font> premarket on high volume the morning after it disclosed an acquisition of a Danish start-up that <i>Variety</i> <a href=\"https://seekingalpha.com/news/3310959-roku-acquisition-points-toward-smart-speaker-entry\" target=\"_blank\">identified as Dynastrom</a>, a sign the company's working to move into whole-house smart speaker applications.</li>    <li>That sets up Roku for a record high at the open.</li>    <li>In filings provided with its third-quarter earnings, the company said it expected full-year revenues to reach or pass $500M in 2017, up from almost $400M a year ago.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311115\" data-linked=\"Roku +5.7% after disclosing Danish acquisition\" data-tweet=\"$ROKU - Roku +5.7% after disclosing Danish acquisition https://seekingalpha.com/news/3311115-rokuplus-5_7-after-disclosing-danish-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3311115-rokuplus-5_7-after-disclosing-danish-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311114\" data-ts=\"1510324109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPC\" target=\"_blank\">TPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311114-tutor-perini-plunges-after-big-q3-miss-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tutor Perini plunges after big Q3 miss, downside guidance</a></h4><ul>     <li>Tutor Perini (NYSE:<a href='https://seekingalpha.com/symbol/TPC' title='Tutor Perini Corporation'>TPC</a>) <font color='red'>-7.3%</font> premarket after posting wide misses on <a href=\"https://seekingalpha.com/news/3310812-tutor-perini-misses-0_26-misses-revenue\" target=\"_blank\">Q3 earnings</a> and revenues, and lowering full-year guidance for earnings and sales.</li>     <li>TPC says Q3 results were affected as various civil and building segment projects are nearing completion and newer projects, are earlier in their project life cycle and are not yet generating expected higher levels of revenue, as well as certain delays in the timing of new awards and project execution activities for previously awarded projects.</li>     <li>Backlog at the end of Q3 totaled $7.5B, up 12% Y/Y and up 20% from year-end 2016, and civil segment backlog rose 54% Y/Y to $4.3B, a new record.</li>     <li>TPC cuts its guidance for FY 2017, now seeing EPS of $1.75-$1.90 vs. its earlier outlook of $2.10-$2.40 and well below $2.25 analyst consensus estimate, and revenues of $5B vs. its prior view of greater than $5.5B and below $5.39 consensus.</li>     <li>However, Canaccord reiterates its Buy rating for TPC even as it trims its stock price target to $32 from $35, still seeing the company's long-term drivers in place and expecting additional large scale civil awards and continued growth in its backlog.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311114\" data-linked=\"Tutor Perini plunges after big Q3 miss, downside guidance\" data-tweet=\"$TPC - Tutor Perini plunges after big Q3 miss, downside guidance https://seekingalpha.com/news/3311114-tutor-perini-plunges-after-big-q3-miss-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3311114-tutor-perini-plunges-after-big-q3-miss-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311112\" data-ts=\"1510323631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311112-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+78%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+28%</font>&nbsp;on Ford <a href=\"https://seekingalpha.com/news/3311102-ekso-bionics-25-percent-premarket-ford-test-eksovest-assembly-line-workers\" target=\"_blank\">test</a> of EksoVest for assembly line workers.</li>     <li><a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='green'>+19%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3310933-real-goods-solar-reports-q3-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='green'>+18%</font>&nbsp;on Q3&nbsp;<a href=\"https://seekingalpha.com/news/3311061-j-c-penney-beats-0_10-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ESEA' title='Euroseas Ltd.'>ESEA</a> <font color='green'>+15%</font>&nbsp;on Q3&nbsp;<a href=\"https://seekingalpha.com/news/3311063-euroseas-beats-0_07-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+14%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+14%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3310746-omeros-beats-0_17-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a> <font color='green'>+13%</font>&nbsp;on positive analyst <a href=\"https://seekingalpha.com/news/3311100-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li>     <li><a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='green'>+12%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3310760-hertz-global-holdings-beats-0_10-revenue-line\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+8%</font>&nbsp;on positive analyst&nbsp;<a href=\"https://seekingalpha.com/news/3311100-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+7%</font>&nbsp;in Q3 <a href=\"https://seekingalpha.com/news/3310754-transenterix-eps-line-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+6%</font>&nbsp;on the <a href=\"https://seekingalpha.com/news/3311093-cheetah-mobile-announces-bytedance-musical-ly-merger\" target=\"_blank\">merger</a> of content aggregator Bytedance and social video app company Musically.</li>     <li><a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='green'>+5%</font>&nbsp;on Q3&nbsp;<a href=\"https://seekingalpha.com/news/3310727-synergy-pharma-beats-0_06-beats-revenue\" target=\"_blank\">result</a></li>     <li><a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+5%</font>&nbsp;on Q3&nbsp;<a href=\"https://seekingalpha.com/news/3310998-arcelormittal-beats-0_32-misses-revenue\" target=\"_blank\">result</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311112\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CREG $EKSO $RGSE - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3311112-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3311112-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311111\" data-ts=\"1510323423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311111-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/RELY' title='Real Industry, Inc.'>RELY</a> <font color='red'>-38%</font>.</li><li><a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>&nbsp;<font color='red'>-20%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3311059-neovasc-prices-equity-offering-shares-10-percent-premarket\" target=\"_blank\">pricing</a> equity offering.</li><li><a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3311085-infinity-pharmas-lead-candidate-ipiminus-549-shows-shows-positive-effect-early-stage\" target=\"_blank\">reporting</a> IPI-549 clinical and translational data.</li><li><a href='https://seekingalpha.com/symbol/LPTH' title='LightPath Technologies, Inc.'>LPTH</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3310855-lightpath-technologies-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>&nbsp;<font color='red'>-14%</font>&nbsp;on price target <a href=\"https://seekingalpha.com/news/3311100-premarket-analyst-action-healthcare\" target=\"_blank\">raised</a> by Citigroup.</li><li><a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3310730-trade-desk-beats-0_08-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/RDFN' title='Redfin'>RDFN</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3310723-redfin-misses-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3310861-quantum-misses-0_17-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ATTO' title='Atento'>ATTO</a> <font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16998505-atento-announces-pricing-secondary-offering-12295-082-ordinary-shares\" target=\"_blank\">pricing</a> secondary offering of ordinary shares.</li><li><a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>&nbsp;<font color='red'>-8%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3311088-frontier-communications-nearly-6-percent-baml-downgrade\" target=\"_blank\">after</a> BAML downgrade.</li><li><a href='https://seekingalpha.com/symbol/OTIC' title='Otonomy'>OTIC</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3310740-acelrx-pharmaceuticals-misses-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3311111\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$RELY $NVCN $INFI - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3311111-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3311111-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311100\" data-ts=\"1510322660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABLX\" target=\"_blank\">ABLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311100-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Ablynx (NASDAQ:<a href='https://seekingalpha.com/symbol/ABLX' title='Ablynx NV'>ABLX</a>) initiated with Buy rating and $26 (26% upside) price target by BofA/Merrill Lynch.</li><li>Jazz Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/JAZZ' title='Jazz Pharmaceuticals, Inc.'>JAZZ</a>) assumed with Neutral rating and $150 (11% upside) price target by H.C. Wainwright.</li><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a>) assume with Buy rating and $7 (220% upside) price target by H.C. Wainwright.</li><li>Teleflex (NYSE:<a href='https://seekingalpha.com/symbol/TFX' title='Teleflex Inc.'>TFX</a>) resumed with Overweight rating and $295 (15% upside) price target by Piper Jaffray.</li><li>Perrigo (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a>) upgraded to Sector Perform with an $86 (2% downside risk) price target by RBC.</li><li>SAGE Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a>) price target raised to $100 (3% upside) from $86 by Needham on brexanolone upside. Upgraded to Buy with a $140 (45% upside) by Chardan Capital Markets.</li><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) upgraded to Buy with a $79 (14% upside) price target by Needham despite possible entry of Amazon into pharmacy. Risk/reward profile attractive.</li><li>UBS AG (NYSE:<a href='https://seekingalpha.com/symbol/UBS' title='UBS Group AG'>UBS</a>) upgraded to Buy by BofA/Merrill Lynch.</li><li>AveXis (NASDAQ:<a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a>) price target raised to $97 (2% downside risk) from $92 by RBC.</li><li>Dynavax (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) price target raised to $25 (25% upside) from $24 by Cantor Fitzgerald after FDA OK of Heplisav-B.</li><li>BioLife Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a>) price target raised to $8 (55% upside) from $7 Maxim Group. Shares up&nbsp;<font color='green'>18%</font>&nbsp;premarket.</li><li>Puma Biotech (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) price target raised to $164 (+29% upside) from $156 by Citigroup after Q3 results.</li><li>Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) downgraded to Neutral with a $2 (27% upside) price target by Roth Capital.</li><li>TrovaGene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) downgraded to Hold by Maxim Group citing its need to raise capital.</li><li>Endo International (NASDAQ:<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) price target lowered to $7 (17% upside) from $9 by Cantor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311100\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ABLX $ABLX $JAZZ - Premarket analyst action - healthcare https://seekingalpha.com/news/3311100-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3311100-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311102\" data-ts=\"1510321655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311102-ekso-bionics-up-25-premarket-on-ford-test-of-eksovest-for-assembly-line-workers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso Bionics up 25% premarket on Ford test of EksoVest for assembly line workers</a></h4><ul><li>Nano cap Ekso Bionics Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>) is up&nbsp;<font color='green'>25%</font>&nbsp;premarket on robust volume in response to Ford's <a href=\"https://media.ford.com/content/fordmedia/fna/us/en/news/2017/11/09/ford-exoskeleton-technology-pilot.html\" target=\"_blank\">announcement </a>that it is testing its upper body exoskeleton, EksoVest, in assembly line workers to reduce the chance of fatigue or injury while performing overhead tasks.</li><li>The device provides adjustable lift assistance of 5 - 15 pounds per arm.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311102\" data-linked=\"Ekso Bionics up 25% premarket on Ford test of EksoVest for assembly line workers\" data-tweet=\"$EKSO - Ekso Bionics up 25% premarket on Ford test of EksoVest for assembly line workers https://seekingalpha.com/news/3311102-ekso-bionics-up-25-premarket-on-ford-test-of-eksovest-for-assembly-line-workers?source=tweet\" data-url=\"https://seekingalpha.com/news/3311102-ekso-bionics-up-25-premarket-on-ford-test-of-eksovest-for-assembly-line-workers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311101\" data-ts=\"1510321518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311101-overstock-gains-continue-davidson-analyst-sees-60-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock gains continue; Davidson analyst sees 60% upside</a></h4><ul><li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>)&nbsp;<font color='green'>surged by 31%&nbsp;</font>yesterday, helped by Wednesday evening's earnings beat <a href=\"https://www.marketwatch.com/story/overstock-shares-rocket-as-sale-of-home-e-commerce-business-is-considered-2017-11-09\" target=\"_blank\">and the idea the company could</a> put its home e-commerce business on the block.</li><li>\"I hear the Gods of Economics whispering that the best model is a brick-and-click model,\" says CEO Patrick Byrne.</li><li>D.A. Davidson bull Tom Forte is upping his bet, boosting the price target to $85 from $57. In addition to the home e-commerce news, Forte thinks Overstock may be able to unlock the value in its Medici Ventures - a portfolio of nine companies involved with blockchain technology.</li><li>Shares are&nbsp;<font color='green'>up another 2.3%</font>&nbsp;premarket to $53.60.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3309979-overstock-com-reports-q3-results\" target=\"_blank\">Overstock.com reports Q3 results</a> (Nov. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311101\" data-linked=\"Overstock gains continue; Davidson analyst sees 60% upside\" data-tweet=\"$OSTK - Overstock gains continue; Davidson analyst sees 60% upside https://seekingalpha.com/news/3311101-overstock-gains-continue-davidson-analyst-sees-60-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3311101-overstock-gains-continue-davidson-analyst-sees-60-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311097\" data-ts=\"1510320907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311097-transenterix-up-10-premarket-after-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransEnterix up 10% premarket after Q3 results</a></h4><ul><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on increased volume on the heels of its Q3 report released after the close yesterday. The numbers were generally in line but investors are more interested in the ramp of Senhance in the U.S. which earned FDA clearance last month.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310754-transenterix-eps-line-misses-revenue\" target=\"_blank\">TransEnterix EPS in-line, misses on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311097\" data-linked=\"TransEnterix up 10% premarket after Q3 results\" data-tweet=\"$TRXC - TransEnterix up 10% premarket after Q3 results https://seekingalpha.com/news/3311097-transenterix-up-10-premarket-after-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3311097-transenterix-up-10-premarket-after-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311093\" data-ts=\"1510320646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311093-cheetah-mobile-announces-bytedance-musical-ly-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile announces Bytedance, Musical.ly merger</a></h4><ul><li>Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) <a href=\"https://seekingalpha.com/pr/16998666-cheetah-mobile-announces-merger-musical-ly-bytedance\" target=\"_blank\">announces</a> the merger of content aggregator Bytedance and social video app company Musical.ly.</li><li>Financial details weren&rsquo;t disclosed but <a href=\"http://variety.com/2017/music/asia/china-bytedance-buying-musical-ly-1202611709/\" target=\"_blank\">Bloomberg estimates</a> $800M while The Wall Street Journal has the potential price as high as $1B. Bytedance has a $20B valuation.</li><li>Musical.ly has 120M users and has struck deals with major US media companies to produce original content for its young user base</li><li>Cheetah Mobile is a Musical.ly investor with a 17.4% stake as of the end of last year.</li><li>Cheetah Mobile shares are&nbsp;<font color='green'>up 3.59%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3309887-cheetah-mobile-15-percent-strategic-agreements-bytedance\" target=\"_blank\">Cheetah Mobile up 15% on strategic agreements with Bytedance</a> (Nov. 8)</li><li>Correction: Post updated to clarify Cheetah Mobile's relationship to the other companies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311093\" data-linked=\"Cheetah Mobile announces Bytedance, Musical.ly merger\" data-tweet=\"$CMCM - Cheetah Mobile announces Bytedance, Musical.ly merger https://seekingalpha.com/news/3311093-cheetah-mobile-announces-bytedance-musical-ly-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3311093-cheetah-mobile-announces-bytedance-musical-ly-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311091\" data-ts=\"1510320479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311091-omeros-q3-beat-propels-shares-up-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros Q3 beat propels shares, up 17% premarket</a></h4><ul><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) is up&nbsp;<font color='green'>17%</font>&nbsp;premarket on light volume after posting <a href=\"https://seekingalpha.com/pr/16998081-omeros-corporation-reports-third-quarter-2017-financial-results\" target=\"_blank\">Q3 numbers</a> after the close yesterday.</li><li>OMIDRIA sales: $21.7M (+92.0%); Net Loss: ($7.5M) (+46.4%); Loss/Share: ($0.16) (+52.9%).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310746-omeros-beats-0_17-beats-revenue\" target=\"_blank\">Omeros beats by $0.17, beats on revenue</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311091\" data-linked=\"Omeros Q3 beat propels shares, up 17% premarket\" data-tweet=\"$OMER - Omeros Q3 beat propels shares, up 17% premarket https://seekingalpha.com/news/3311091-omeros-q3-beat-propels-shares-up-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3311091-omeros-q3-beat-propels-shares-up-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311088\" data-ts=\"1510320250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311088-frontier-communications-down-nearly-6-after-baml-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier Communications down nearly 6% after BAML downgrade</a></h4><ul><li>\"The equity story at Frontier (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is now in jeopardy,\" says analyst David Barden, downgrading to Underperform and cutting his price target to a Street-low $4.</li><li>The company, he says, faces \"substantial towers of debt.\"</li><li>Source: Bloomberg's Danielle Smith</li><li>Shares&nbsp;<font color='red'>down 5.8%</font>&nbsp;premarket to $7.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311088\" data-linked=\"Frontier Communications down nearly 6% after BAML downgrade\" data-tweet=\"$FTR - Frontier Communications down nearly 6% after BAML downgrade https://seekingalpha.com/news/3311088-frontier-communications-down-nearly-6-after-baml-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3311088-frontier-communications-down-nearly-6-after-baml-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311087\" data-ts=\"1510320118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311087-arcelormittalplus-5-on-strong-q3-upbeat-global-steel-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal +5% on strong Q3, upbeat global steel outlook</a></h4><ul>     <li>ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>) <font color='green'>+4.7%</font> premarket after easily beating <a href=\"https://seekingalpha.com/news/3310998-arcelormittal-beats-0_32-misses-revenue\" target=\"_blank\">Q3 earnings</a> expectations with revenues rising more than 21% to $17.08B from $14.52B a year earlier.</li>     <li>Q3 steel shipments rose 6.8% Y/Y and 1% Q/Q to 21.7M metric tons, shipping more steel in all regions except Europe, but even there the fall was <a href=\"http://www.reuters.com/article/arcelormittal-results/update-1-arcelormittal-upbeat-about-2018-after-strong-third-quarter-idUSL8N1NG0XH\" target=\"_blank\">less than the usual seasonal decline</a> near the end of the year; Q3 iron ore shipments climbed 8.1% Y/Y to 15M metric tons.</li>     <li>&ldquo;Operating conditions continue to improve, with key indicators including the ArcelorMittal weighted PMI implying a positive outlook for 2018,&rdquo; says CEO Lakshmi Mittal.</li>     <li>Citing improved market conditions, MT says it now expects to increase its FY 2017 investment in working capital to $2B, up from earlier guidance of $1.5B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3311087\" data-linked=\"ArcelorMittal +5% on strong Q3, upbeat global steel outlook\" data-tweet=\"$MT - ArcelorMittal +5% on strong Q3, upbeat global steel outlook https://seekingalpha.com/news/3311087-arcelormittalplus-5-on-strong-q3-upbeat-global-steel-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3311087-arcelormittalplus-5-on-strong-q3-upbeat-global-steel-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311085\" data-ts=\"1510320020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311085-infinity-pharmas-lead-candidate-ipiminus-549-shows-shows-positive-effect-in-early-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharma&#39;s lead candidate IPI-549 shows shows positive effect in early-stage monotherapy study but shares down 16% premarket</a></h4><ul><li>Investors appear disappointed with <a href=\"http://investors.infi.com/news-releases/news-release-details/infinity-pharmaceuticals-reports-ipi-549-clinical-and\" target=\"_blank\">early-stage data</a> for Infinity Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a>) lead candidate IPI-549. Results from the monotherapy dose-escalation portion of a Phase 1/1b study showed a 44% clinical benefit rate which the company says is defined as those who remained on treatment for at least 16 weeks. There was one partial responder, a patient with advanced peritoneal mesothelioma.</li><li>The data are being presented today at the SITC Annual Meeting in National Harbor, MD.</li><li>The company is evaluating IPI-549 as a standalone therapy and in combination with Bristol-Myers Squibb's (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) Opdivo (nivolumab) in patients with advanced solid tumors. The combination expansion cohorts should be initiated by year-end.</li><li><a href=\"http://www.infi.com/home/research-development/pi3k/\" target=\"_blank\">IPI-549</a>&nbsp;is an orally available inhibitor of an enzyme called phosphoinositide-3-kinase (PI3K)-gamma that plays a key role in inflammation, immunity and cancer.</li><li>Shares are down&nbsp;<font color='red'>16%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311085\" data-linked=\"Infinity Pharma&#39;s lead candidate IPI-549 shows shows positive effect in early-stage monotherapy study but shares down 16% premarket\" data-tweet=\"$INFI $INFI $BMY - Infinity Pharma&#39;s lead candidate IPI-549 shows shows positive effect in early-stage monotherapy study but shares down 16% premarket https://seekingalpha.com/news/3311085-infinity-pharmas-lead-candidate-ipiminus-549-shows-shows-positive-effect-in-early-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3311085-infinity-pharmas-lead-candidate-ipiminus-549-shows-shows-positive-effect-in-early-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311074\" data-ts=\"1510318810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311074-bitcoin-down-1k-over-last-two-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin down more than $1K over last two days</a></h4><ul><li>The price of the crypto surged through $7,800 two days ago after the suspension of the hard fork software upgrade. But it fell sharply yesterday, and is&nbsp;<font color='red'>down another 4%</font>&nbsp;today to $6,800.</li><li>In the meantime, <a href=\"https://www.wsj.com/articles/bitcoin-the-worlds-most-dramatic-bubble-ever-1510303095\" target=\"_blank\">the <em>WSJ</em>'s Steven Russolillo says</a> tulips, the Internet mania, and the housing bubble have nothing on bitcoin. In the last 15 months, bitcoin has surged nearly eight times as much as the Nasdaq did in the last 15 months of its epic boom.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3311074\" data-linked=\"Bitcoin down more than $1K over last two days\" data-tweet=\"$GBTC $GBTC $COIN - Bitcoin down more than $1K over last two days https://seekingalpha.com/news/3311074-bitcoin-down-1k-over-last-two-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3311074-bitcoin-down-1k-over-last-two-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311064\" data-ts=\"1510317629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311064-onconova-prices-direct-stock-offering-1_50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova prices direct stock offering at $1.50</a></h4><ul><li>Onconova (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a>) <a href=\"https://seekingalpha.com/pr/16998619-onconova-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> its direct offering of ~920K shares of common stock to certain investors at $1.50 per share. Net proceeds will fund clinical trials, R&amp;D and general corporate purposes.</li><li>Yesterday's close was $1.86.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311064\" data-linked=\"Onconova prices direct stock offering at $1.50\" data-tweet=\"$ONTX - Onconova prices direct stock offering at $1.50 https://seekingalpha.com/news/3311064-onconova-prices-direct-stock-offering-1_50?source=tweet\" data-url=\"https://seekingalpha.com/news/3311064-onconova-prices-direct-stock-offering-1_50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311063\" data-ts=\"1510317559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESEA\" target=\"_blank\">ESEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311063-euroseas-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Euroseas beats by $0.07, beats on revenue</a></h4><ul><li>Euroseas (NASDAQ:<a href='https://seekingalpha.com/symbol/ESEA' title='Euroseas Ltd.'>ESEA</a>): Q3 EPS of -$0.06 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $11.07M (+53.1% Y/Y) <font color='green'>beats by $1.99M</font>.</li><li>Shares <font color='green'>+17.51%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16998669-euroseas-ltd-reports-results-nine-month-period-quarter-ended-september-30-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3311063\" data-linked=\"Euroseas beats by $0.07, beats on revenue\" data-tweet=\"$ESEA - Euroseas beats by $0.07, beats on revenue https://seekingalpha.com/news/3311063-euroseas-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3311063-euroseas-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311061\" data-ts=\"1510317464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311061-j-c-penney-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney beats by $0.10, beats on revenue</a></h4><ul><li>J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>): Q3 EPS of -$0.33 <font color='green'>beats by $0.10</font>.</li><li>Revenue of $2.81B (-1.7% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+11.64%</font> PM.</li><li><a href='http://ir.jcpenney.com/phoenix.zhtml?c=70528&p=irol-newsCompanyArticle&ID=2316173'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3311061\" data-linked=\"J.C. Penney beats by $0.10, beats on revenue\" data-tweet=\"$JCP - J.C. Penney beats by $0.10, beats on revenue https://seekingalpha.com/news/3311061-j-c-penney-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3311061-j-c-penney-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311059\" data-ts=\"1510317329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311059-neovasc-prices-equity-offering-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc prices equity offering; shares down 10% premarket</a></h4><ul><li>Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) takes first prize in 2017 for the most convoluted equity offering. It has <a href=\"https://seekingalpha.com/pr/16998524-neovasc-announces-us-65-million-underwritten-offering-units-consisting-common-shares-warrants\" target=\"_blank\">priced</a>&nbsp;~6.6M Series A Units and ~19.1M Series B Units at $1.46 per Unit. Gross proceeds should be ~$37.5M.</li><li>Each Series A Unit consists of one common share, one Series A Warrant, one Series B Warrant and 0.40 of a Series C Warrant.</li><li>Each Series B Unit consists of either one Unit Share or one prefunded Series D Warrant plus one Series A Warrant plus one Series B Warrant plus 0.40 of a Series C Warrant plus a Series F Warrant.</li><li>Each five-year Series A Warrant entitles the holder to buy one share of common at $1.61. Each two-year Series B Warrant entitles the holder to buy one share of common at $1.61. Each whole two-year Series C Warrant entitles the holder to buy one Series C Unit comprised of one common share, one Series A Warrant and one Series B Warrant.</li><li>Each five-year Series D Warrant entitles the holder to buy one share of common at $1.46 at a nominal price of $0.01 per Warrant. Each two-year Series F Warrant entitles the holder to buy one share of common at $1.61.</li><li>Concurrently, the company will execute a private placement of $32.75M of senior secured convertible notes plus Series E Warrants yielding gross proceeds of ~$27.8M. Each Seres E Warrant entitles the holder to buy one share of common. The 18-month Notes will be issued at a discounted price of $850 per $1,000 principal amount and will bear no interest (15% in the event of default).</li><li>Shares are down&nbsp;<font color='red'>10%&nbsp;</font>premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3311059\" data-linked=\"Neovasc prices equity offering; shares down 10% premarket\" data-tweet=\"$NVCN - Neovasc prices equity offering; shares down 10% premarket https://seekingalpha.com/news/3311059-neovasc-prices-equity-offering-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3311059-neovasc-prices-equity-offering-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3311058\" data-ts=\"1510317324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3311058-western-digital-resumes-stock-repurchase-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital resumes stock repurchase program</a></h4><ul><li>        Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) will resume potential stock repurchases under a previous program that was halted after its SanDisk acquisition last year.</li><li>               The board-approved program was originally authorized for $5B with $2.1B now remaining.&nbsp;</li><li>                  The repurchase program remains effective until February 3, 2020.   </li><li>Western Digital shares are&nbsp;<font color='green'>up 1.16%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310510-toshibas-q2-posts-76-percent-profit-increase-departing-chip-unit\" target=\"_blank\">Toshiba's Q2 posts 76% profit increase from departing chip unit</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3311058\" data-linked=\"Western Digital resumes stock repurchase program\" data-tweet=\"$WDC - Western Digital resumes stock repurchase program https://seekingalpha.com/news/3311058-western-digital-resumes-stock-repurchase-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3311058-western-digital-resumes-stock-repurchase-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3310998\" data-ts=\"1510308497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3310998-arcelormittal-beats-0_32-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal beats by $0.32, misses on revenue</a></h4><ul><li>ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>): Q3 EPS of $1.18 <font color='green'>beats by $0.32</font>.</li><li>Revenue of $17.64B (+21.5% Y/Y) <font color='red'>misses by $260M</font>.</li><li>Shares <font color='green'>+2.6%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/16998523-arcelormittal-reports-third-quarter-2017-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3310998\" data-linked=\"ArcelorMittal beats by $0.32, misses on revenue\" data-tweet=\"$MT - ArcelorMittal beats by $0.32, misses on revenue https://seekingalpha.com/news/3310998-arcelormittal-beats-0_32-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3310998-arcelormittal-beats-0_32-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}